Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 8
1996 17
1997 3
1998 4
1999 2
2000 6
2001 6
2002 7
2003 3
2004 4
2005 10
2006 10
2007 8
2008 7
2009 15
2010 17
2011 9
2012 17
2013 19
2014 20
2015 13
2016 11
2017 8
2018 13
2019 15
2020 11
2021 2
2022 4
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
Iobitridol: a review of its use as a contrast medium in diagnostic imaging.
McCormack PL. McCormack PL. Clin Drug Investig. 2013 Feb;33(2):155-66. doi: 10.1007/s40261-013-0055-3. Clin Drug Investig. 2013. PMID: 23341290 Review.
Iobitridol was generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast media. Thus, iobitridol is an effective intravascular agent for contrast enhancement in diagnostic imaging....
Iobitridol was generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast …
Pharmacologic profile of iobitridol, a nonionic iodinated contrast medium.
Idee JM, Bault C, Beaufils H, Berthommier C, Cambar J, Corot C, Doucet D, Hartl C, Jaudon MC, Jacquiaud C, Lakhdar B, Potier M, santus R, Torcherie S, Vaudon E, Bonnemain B. Idee JM, et al. Acta Radiol Suppl. 1996;400:35-48. Acta Radiol Suppl. 1996. PMID: 8619351 Review.
The present article combines and summarizes the preclinic studies carried out in vitro and in vivo to determine the pharmacologic and biochemical profile of iobitridol, a new nonionic iodinated low-osmolality contrast medium (CM). ...The in vivo studies were performed unde …
The present article combines and summarizes the preclinic studies carried out in vitro and in vivo to determine the pharmacologic and bioche …
5-[3-Hydroxy-2-hydroxymethyl-propionamido)-N,N´-dimethyl-N,N´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide.
Cheng KT. Cheng KT. 2006 May 16 [updated 2008 Apr 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2006 May 16 [updated 2008 Apr 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641966 Free Books & Documents. Review.
This was generally achieved by conversion of the carboxyl groups to hydroxyalkylamide groups (9). As a low-osmolar nonionic monomer, iobitridol was developed in an effort to increase the safety and tolerance of X-ray contrast agents. ...Iobitridol is not commerciall …
This was generally achieved by conversion of the carboxyl groups to hydroxyalkylamide groups (9). As a low-osmolar nonionic monomer, iobi …
Iobitridol, a new nonionic low-osmolality contrast agent, and iohexol. Impact on renal histology in the rat.
Beaufils H, Idée JM, Berthommier C, Balut C, Bourbouze R, Nimier K, Chicandre-Jouanneau C, Bonnemain B. Beaufils H, et al. Invest Radiol. 1995 Jan;30(1):33-9. doi: 10.1097/00004424-199501000-00005. Invest Radiol. 1995. PMID: 7759214
Iobitridol also induced fewer congestive lesions in the glomerular capillaries than iohexol (4 of 14 versus 10 of 14, respectively; P < .05) and saline (5 of 6; P < .05). It is difficult to explain the lesser degree of cytoplasmic vacuolization using standard physico …
Iobitridol also induced fewer congestive lesions in the glomerular capillaries than iohexol (4 of 14 versus 10 of 14, respectively; P …
Comparative toxic effects of iobitridol and iohexol on the kidney.
Wasaki M, Kawamura H, Sugimoto J, Shimada M, Satoh Y, Tanaka E, Gemba M. Wasaki M, et al. Invest Radiol. 1998 Jul;33(7):393-400. doi: 10.1097/00004424-199807000-00003. Invest Radiol. 1998. PMID: 9659591
RATIONALE AND OBJECTIVES: The authors compare the toxic effects of iobitridol and iohexol, which are nonionic contrast media with equivalent osmolalities and viscosities on the kidney. ...In the rat renal slice system, the iobitridol treatment had significantly less …
RATIONALE AND OBJECTIVES: The authors compare the toxic effects of iobitridol and iohexol, which are nonionic contrast media with equ …
Safety Analysis of Iobitridol as a Nonionic Contrast Medium: A Postmarketing Multicenter Surveillance Study With 94,960 Patients Almost 20 Years After Introduction.
Gorodetski B, Heine O, Wolf M, Collettini F, Hamm B, Darmon-Kern E, Penzkofer T. Gorodetski B, et al. Invest Radiol. 2020 Mar;55(3):144-152. doi: 10.1097/RLI.0000000000000620. Invest Radiol. 2020. PMID: 31977601
OBJECTIVES: Our study sought to reevaluate the safety and diagnostic efficacy of iobitridol as a nonionic contrast medium after almost 20 years of use. ...No statistically significant difference in the prevalence of AE between the different combination of cortisone and/or …
OBJECTIVES: Our study sought to reevaluate the safety and diagnostic efficacy of iobitridol as a nonionic contrast medium after almos …
Pharmacokinetic profile of iobitridol.
Dencausse A, Violas X, Feldman H, Havard P, Chambon C. Dencausse A, et al. Acta Radiol Suppl. 1996;400:25-34. Acta Radiol Suppl. 1996. PMID: 8619349
Iobitridol (Xenetix) is a new triiodinated monomer, nonionic, low-osmolality contrast agent. ...
Iobitridol (Xenetix) is a new triiodinated monomer, nonionic, low-osmolality contrast agent. ...
238 results